Researchers at the International Centre for Genetic Engineering and Biotechnology in New Delhi said they are making strides with a vaccine for the dengue virus, which is being developed with technology used to make hepatitis B vaccine. Preclinical tests showed the vaccine addressed all of the four dengue virus strains, researchers said. Human trials are estimated to be at least five years away.

Related Summaries